# Tsingke Highlights How Biotech Teams Can Evaluate and Advance Antibody Candidates at PEGS Europe 2026

- Source: PR Newswire M&A
- Published: 2026-11-20T14:18:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/tsingke-highlights-how-biotech-teams-can-evaluate-and-advance-antibody-candidates-at-pegs-europe-2026-302946710.html
- Canonical: https://groundlevelnews.com/story/tsingke-highlights-how-biotech-teams-can-evaluate-and-advance-antibody-27ed07/

From early antibody hits to engineered formats and antibody–oligonucleotide conjugates, Tsingke helps R&D teams generate the data they need to make the next development decision. LISBON, Portugal, Nov. 20, 2026 /PRNewswire/ -- An antibody that binds its target is a starting point for drug...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
